<!DOCTYPE html><html><head><title>Help for package nmaINLA</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
<link href="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/themes/prism.min.css" rel="stylesheet" />
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.css">
<script type="text/javascript">
const macros = { "\\R": "\\textsf{R}", "\\code": "\\texttt"};
function processMathHTML() {
    var l = document.getElementsByClassName('reqn');
    for (let e of l) { katex.render(e.textContent, e, { throwOnError: false, macros }); }
    return;
}</script>
<script defer src="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.js"
    onload="processMathHTML();"></script>
<link rel="stylesheet" type="text/css" href="R-nav.css" />
</head><body><div class="container"><nav aria-label="Topic Navigation">
<div class="dropdown-menu">
<h1>Package {nmaINLA}</h1>
<h2>Contents</h2>
<ul class="menu">
<li><a href='#Anestheticdat'><p>Data for the Anesthetic example in Greco et al. (2013)</p></a></li>
<li><a href='#Certolizumabdat'><p>Data for the Certolizumab NMA-network discussed in Dias et al. (2013)</p></a></li>
<li><a href='#CooperStrokedat'><p>Data for the stroke prevention NMA-network discussed in Cooper et al. (2009)</p></a></li>
<li><a href='#create_INLA_dat'><p>Prepare network meta-analysis dataset for INLA.</p></a></li>
<li><a href='#create_INLA_dat_pair'><p>Prepare pairwise meta-analysis dataset for INLA.</p></a></li>
<li><a href='#Diabetesdat'><p>Data for the Diabetes example in Senn et al. (2013)</p></a></li>
<li><a href='#Dietaryfatdat'><p>Data for the Dietary fat example in Dias et al. (2011)</p></a></li>
<li><a href='#Flourdat'><p>Data for the Flour NMA example in Dias et al. (2010)</p></a></li>
<li><a href='#IncDiabetesdat'><p>Data for the Incident Diabetes example in Elliott et al. (2007)</p></a></li>
<li><a href='#KussHeartdat'><p>Data for the ischemic heart disease sparse pairwise meta-analysis discussed in Kuss (2014)</p></a></li>
<li><a href='#meta_inla'><p>Fitting a pairwise meta-analysis model using INLA.</p></a></li>
<li><a href='#nma_inla'><p>Fitting a network meta-analysis model using INLA</p></a></li>
<li><a href='#nmaINLA'><p>nmaINLA: Network meta-analysis using INLA</p></a></li>
<li><a href='#Parkinsondat'><p>Data for the Parkinson NMA-network discussed in Dias et al. (2013)</p></a></li>
<li><a href='#plot_nma'><p>Plot a network plot</p></a></li>
<li><a href='#print.nma_inla'><p>Print nmainla object</p></a></li>
<li><a href='#Smokdat'><p>Data for the smoking cessation NMA-network discussed in Dias et al. (2010)</p></a></li>
<li><a href='#Strokedat'><p>Data for the Stroke NMA regression discussed in Batson et al. (2016)</p></a></li>
<li><a href='#TBdat'><p>Trials investigating effectiveness of the BCG vaccine against TB</p></a></li>
<li><a href='#Thrombdat'><p>Data for the thrombolytic NMA-network discussed in Dias et al. (2010)</p></a></li>
<li><a href='#Woodsdat'><p>Data for the Woods example in Woods et al. (2010)</p></a></li>
</ul>
</div>
<hr>
</nav>
<main>
<table>
<tr>
<td>Type:</td>
<td>Package</td>
</tr>
<tr>
<td>Title:</td>
<td>Network Meta-Analysis using Integrated Nested Laplace
Approximations</td>
</tr>
<tr>
<td>Version:</td>
<td>1.1.0</td>
</tr>
<tr>
<td>Date:</td>
<td>2021-07-18</td>
</tr>
<tr>
<td>Description:</td>
<td>Performs network meta-analysis using integrated nested Laplace approximations ('INLA') 
             which is described in Guenhan, Held, and Friede (2018) &lt;<a href="https://doi.org/10.1002%2Fjrsm.1285">doi:10.1002/jrsm.1285</a>&gt;. 
             Includes methods to assess the heterogeneity and inconsistency in the network. 
             Contains more than ten different network meta-analysis dataset. 
             'INLA' package can be obtained from <a href="https://www.r-inla.org">https://www.r-inla.org</a>. </td>
</tr>
<tr>
<td>License:</td>
<td><a href="https://www.r-project.org/Licenses/GPL-2">GPL-2</a> | <a href="https://www.r-project.org/Licenses/GPL-3">GPL-3</a> [expanded from: GPL (&ge; 2)]</td>
</tr>
<tr>
<td>LazyData:</td>
<td>TRUE</td>
</tr>
<tr>
<td>Depends:</td>
<td>R (&ge; 2.10)</td>
</tr>
<tr>
<td>Additional_repositories:</td>
<td><a href="https://inla.r-inla-download.org/R/stable/">https://inla.r-inla-download.org/R/stable/</a></td>
</tr>
<tr>
<td>RoxygenNote:</td>
<td>7.1.1</td>
</tr>
<tr>
<td>Suggests:</td>
<td>INLA, knitr, testthat</td>
</tr>
<tr>
<td>VignetteBuilder:</td>
<td>knitr</td>
</tr>
<tr>
<td>URL:</td>
<td><a href="https://github.com/gunhanb/nmaINLA">https://github.com/gunhanb/nmaINLA</a></td>
</tr>
<tr>
<td>BugReports:</td>
<td><a href="https://github.com/gunhanb/nmaINLA/issues">https://github.com/gunhanb/nmaINLA/issues</a></td>
</tr>
<tr>
<td>Encoding:</td>
<td>UTF-8</td>
</tr>
<tr>
<td>NeedsCompilation:</td>
<td>no</td>
</tr>
<tr>
<td>Packaged:</td>
<td>2021-07-18 19:53:07 UTC; burakgunhan</td>
</tr>
<tr>
<td>Author:</td>
<td>Burak Kuersad Guenhan
    <a href="https://orcid.org/0000-0002-7454-8680"><img alt="ORCID iD"src="https://cloud.R-project.org/web/orcid.svg" style="width:16px; height:16px; margin-left:4px; margin-right:4px; vertical-align:middle" /></a> [aut, cre]</td>
</tr>
<tr>
<td>Maintainer:</td>
<td>Burak Kuersad Guenhan &lt;burakgunhan@gmail.com&gt;</td>
</tr>
<tr>
<td>Repository:</td>
<td>CRAN</td>
</tr>
<tr>
<td>Date/Publication:</td>
<td>2021-07-21 22:10:02 UTC</td>
</tr>
</table>
<hr>
<h2 id='Anestheticdat'>Data for the Anesthetic example in Greco et al. (2013)</h2><span id='topic+Anestheticdat'></span>

<h3>Description</h3>

<p>Greco et al. (2013) considered four anaesthetic agents used in cardiac surgery
(called here 1, 2, 3 and 4) and investigated through NMA.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Anestheticdat
</code></pre>


<h3>Format</h3>

<p>An object of class <code>data.frame</code> with 30 rows and 10 columns.
</p>


<h3>Source</h3>

<p>Greco, T., Landoni, G., Biondi-Zoccai, G., D'Ascenzo, F. and Zangrillo, A., 2013.
A Bayesian network meta-analysis for binary outcome: how to do it. Statistical methods in
medical research, p.0962280213500185.
</p>

<hr>
<h2 id='Certolizumabdat'>Data for the Certolizumab NMA-network discussed in Dias et al. (2013)</h2><span id='topic+Certolizumabdat'></span>

<h3>Description</h3>

<p>Data are available from a review of trials of certolizumab pegol (CZP)
for the treatment of rheumatoid arthritis in patients who had failed
on disease-modifying antirheumatic drugs, including methotrexate (MTX). 20
Twelve MTX controlled trials were identified, comparing 6 different
treatments with placebo. The primary outcome is improving by at least 50
of Rheumatology scale (ACR50) at 6 months. A trial-specificc covariate, the mean disease duration
in years for patients, is also given.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Certolizumabdat
</code></pre>


<h3>Format</h3>

<p>An object of class <code>data.frame</code> with 12 rows and 9 columns.
</p>


<h3>Source</h3>

<p>Dias, S., Sutton, A.J., Welton, N.J. and Ades, A.E., 2013.
Evidence synthesis for decision making 3 heterogeneity-subgroups,
meta-regression, bias, and bias-adjustment. Medical Decision Making, 33(5),
pp.618-640.
</p>

<hr>
<h2 id='CooperStrokedat'>Data for the stroke prevention NMA-network discussed in Cooper et al. (2009)</h2><span id='topic+CooperStrokedat'></span>

<h3>Description</h3>

<p>The stroke prevention dataset describes a network comparing 17 treatments with 26 trials.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>CooperStrokedat
</code></pre>


<h3>Format</h3>

<p>A data frame with 26 observations on the following 17 variables.
</p>

<dl>
<dt><code>r1</code></dt><dd><p>Number of events (responses) in the baseline treatment (treatment
1).</p>
</dd>
<dt><code>r2</code></dt><dd><p>Number of events (responses) in the second study arm treatment
(treatment 2).</p>
</dd>
<dt><code>r3</code></dt><dd><p>Number of events (responses) in the third study arm treatment
(treatment 3).</p>
</dd>
<dt><code>r4</code></dt><dd><p>Number of events (responses) in the third study arm treatment
(treatment 4).</p>
</dd>
<dt><code>r5</code></dt><dd><p>Number of events (responses) in the third study arm treatment
(treatment 5).</p>
</dd>
<dt><code>n1</code></dt><dd><p>Total number of study participants in the baseline
treatment (treatment 1).</p>
</dd>
<dt><code>n2</code></dt><dd><p>Total number of study participants in the second study arm
treatment (treatment 2).</p>
</dd>
<dt><code>n3</code></dt><dd><p>Total number of study participants in the second study arm
treatment (treatment 3).</p>
</dd>
<dt><code>n4</code></dt><dd><p>Total number of study participants in the second study arm
treatment (treatment 4).</p>
</dd>
<dt><code>n5</code></dt><dd><p>Total number of study participants in the second study arm
treatment (treatment 5).</p>
</dd>
<dt><code>t1</code></dt><dd><p>Indicator variable identifying treatment 1.</p>
</dd>
<dt><code>t2</code></dt><dd><p>Indicator variable identifying treatment 2.</p>
</dd>
<dt><code>t3</code></dt><dd><p>Indicator variable identifying treatment 3.</p>
</dd>
<dt><code>t4</code></dt><dd><p>Indicator variable identifying treatment 4.</p>
</dd>
<dt><code>t5</code></dt><dd><p>Indicator variable identifying treatment 5.</p>
</dd>
<dt><code>na</code></dt><dd><p>Indicator with number of arms in trial.</p>
</dd>
<dt><code>cov</code></dt><dd><p>Covariate, study-specific covariates</p>
</dd>
<dt><code>des</code></dt><dd><p>Design, the set of treatments included in each study</p>
</dd>
</dl>



<h3>Source</h3>

<p>Cooper, N.J., Sutton, A.J., Morris, D., Ades, A.E. and Welton, N.J., 2009. Addressing between-study
heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments
in individuals with non-rheumatic atrial fibrillation. Statistics in medicine, 28(14), pp.1861-1881.
</p>

<hr>
<h2 id='create_INLA_dat'>Prepare network meta-analysis dataset for INLA.</h2><span id='topic+create_INLA_dat'></span>

<h3>Description</h3>

<p><code>create_INLA_dat</code> converts datasets in the one-study-per-row format to one-arm-per-row format
, then adds indicator (dummy) variables for the basic contrasts,
heterogeneity random effects and design-specific inconsistency random effects and for
correlated multi-arm trials.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>create_INLA_dat(
  dat = dat,
  armVars = c(treatment = "t", responders = "r", sampleSize = "n"),
  covariate = "cov",
  design = "des",
  nArmsVar = "na"
)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="create_INLA_dat_+3A_dat">dat</code></td>
<td>
<p>Data in one-study-per-row format.</p>
</td></tr>
<tr><td><code id="create_INLA_dat_+3A_armvars">armVars</code></td>
<td>
<p>Vector of per-arm variables
The name of each component will be the column name in the resulting dataset.</p>
</td></tr>
<tr><td><code id="create_INLA_dat_+3A_covariate">covariate</code></td>
<td>
<p>Optional. Vector of study-specific covariate</p>
</td></tr>
<tr><td><code id="create_INLA_dat_+3A_design">design</code></td>
<td>
<p>Optional. Vector of study-specific design. We refer design for
the set of treatments in each trial.</p>
</td></tr>
<tr><td><code id="create_INLA_dat_+3A_narmsvar">nArmsVar</code></td>
<td>
<p>Variable holding the number of arms for each study.</p>
</td></tr>
</table>


<h3>Details</h3>

<p>The resulting data.frame can be used as data argument in <code>nma_inla</code>.
</p>


<h3>Value</h3>

<p>A data frame with the generated coloumns.
</p>


<h3>Author(s)</h3>

<p>Burak Kuersad Guenhan, <a href="mailto:burak.gunhan@med.uni-goettingen.de">burak.gunhan@med.uni-goettingen.de</a>,
Rafael Sauter and Gert van Valkenhoef
</p>


<h3>See Also</h3>

<p><code>gemtc::mtc.data.studyrow</code>
</p>


<h3>Examples</h3>

<pre><code class='language-R'>data('Smokdat')
## Create the dataset suitable for INLA
SmokdatINLA &lt;- create_INLA_dat(dat = Smokdat, armVars = c('treatment' = 't', 'responders' = 'r'
,'sampleSize' = 'n'), nArmsVar = 'na')
## Check that the data are correct
print(SmokdatINLA)
</code></pre>

<hr>
<h2 id='create_INLA_dat_pair'>Prepare pairwise meta-analysis dataset for INLA.</h2><span id='topic+create_INLA_dat_pair'></span>

<h3>Description</h3>

<p><code>create_INLA_dat_pair</code> creates two dataframes, one to use in
a contrast based and the other in an arm-based pairwise meta-analysis.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>create_INLA_dat_pair(ntrt, nctrl, ptrt, pctrl, cov = NULL)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="create_INLA_dat_pair_+3A_ntrt">ntrt</code></td>
<td>
<p>Number of subjects in treatment arm</p>
</td></tr>
<tr><td><code id="create_INLA_dat_pair_+3A_nctrl">nctrl</code></td>
<td>
<p>Number of subjects in control arm</p>
</td></tr>
<tr><td><code id="create_INLA_dat_pair_+3A_ptrt">ptrt</code></td>
<td>
<p>Number of events in treatment arm</p>
</td></tr>
<tr><td><code id="create_INLA_dat_pair_+3A_pctrl">pctrl</code></td>
<td>
<p>Number of events in treatment arm</p>
</td></tr>
<tr><td><code id="create_INLA_dat_pair_+3A_cov">cov</code></td>
<td>
<p>Optional argument to include a covariate in the model</p>
</td></tr>
</table>


<h3>Details</h3>

<p>The resulting data.frame can be used as data argument in
<code>meta_inla</code>.
</p>


<h3>Value</h3>

<p>A list of two dataframe objects
</p>


<h3>Examples</h3>

<pre><code class='language-R'>data('TBdat')
## Create the dataset suitable for INLA
TBdatINLA &lt;- create_INLA_dat_pair(TBdat$TRT, TBdat$CON, TBdat$TRTTB, TBdat$CONTB)

## Check that the data are correct
print(TBdatINLA)
</code></pre>

<hr>
<h2 id='Diabetesdat'>Data for the Diabetes example in Senn et al. (2013)</h2><span id='topic+Diabetesdat'></span>

<h3>Description</h3>

<p>Results from 26 trials examining the effectiveness of glucose-lowering agents in
patients with type 2 diabetes.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Diabetesdat
</code></pre>


<h3>Format</h3>

<p>An object of class <code>data.frame</code> with 26 rows and 11 columns.
</p>


<h3>Source</h3>

<p>Senn, S., Gavini, F., Magrez, D., &amp; Scheen, A. (2013). Issues in
performing a network meta-analysis. Statistical Methods in Medical
Research, 22, 169&ndash;189.
</p>

<hr>
<h2 id='Dietaryfatdat'>Data for the Dietary fat example in Dias et al. (2011)</h2><span id='topic+Dietaryfatdat'></span>

<h3>Description</h3>

<p>In a Cochrane Review of randomised controlled trials to assess the effect of change in dietary
fats on total and cardiovascular mortality, 104 data extracted was in the form of rates and given
as the number of events per person-years observed.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Dietaryfatdat
</code></pre>


<h3>Format</h3>

<p>An object of class <code>data.frame</code> with 10 rows and 10 columns.
</p>


<h3>Source</h3>

<p>Dias, S., Welton, N.J., Sutton, A.J. &amp; Ades, A.E. NICE DSU Technical Support Document 2:
A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of
Randomised Controlled Trials. 2011; last updated September 2016; available from
http://www.nicedsu.org.uk
</p>

<hr>
<h2 id='Flourdat'>Data for the Flour NMA example in Dias et al. (2010)</h2><span id='topic+Flourdat'></span>

<h3>Description</h3>

<p>The flour dataset describes a network comparing 6 treatments with 130 trials.
There are 121 pairwise comparisons, 8 three-arm trials and 1 four-arm trial. The main outcome
is caries increment, as measured by the change in decayed, missing, and filled tooth surfaces
(DMFS) in the permanent dentition of children. Data that are available for study i include the
mean caries increment in trial i arm k, y ik, the number of patients at risk in each trial arm, n ik,
the time that individuals are at risk in arm k of study i, t i (measured as the trial follow-up
time, which is the same for both arms) and the interventions being compared.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Flourdat
</code></pre>


<h3>Format</h3>

<p>An object of class <code>data.frame</code> with 130 rows and 20 columns.
</p>


<h3>Source</h3>

<p>Dias, S., Welton, N.J., Marinho, V.C.C., Salanti, G., Higgins, J.P.T. and Ades, A.E., 2010.
Estimation and adjustment of bias in randomized evidence by using mixed treatment comparison meta-analysis.
Journal of the Royal Statistical Society: Series A (Statistics in Society), 173(3), pp.613-629.
</p>

<hr>
<h2 id='IncDiabetesdat'>Data for the Incident Diabetes example in Elliott et al. (2007)</h2><span id='topic+IncDiabetesdat'></span>

<h3>Description</h3>

<p>An example of network meta-analysis for binary outcomes with follow-up times reported.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>IncDiabetesdat
</code></pre>


<h3>Format</h3>

<p>An object of class <code>data.frame</code> with 22 rows and 12 columns.
</p>


<h3>Details</h3>

<p>This network meta-analysis is studied by Elliott and Meyer (2007) to assess the effects of an
ti-hypertensive agents on incident diabetes. Treatment IDs represent 1) diuretic; 2) placebo;
3) beta-blocker; 4) CCB; 5) ACE inhibitor; and 6) ARB.
</p>


<h3>Source</h3>

<p>Elliott WJ and Meyer PM (2007). &quot;Incident diabetes in clinical trials of antihypertensive
drugs: a network meta-analysis.&quot; Lancet 369(9557), 201-7.
</p>

<hr>
<h2 id='KussHeartdat'>Data for the ischemic heart disease sparse pairwise meta-analysis discussed in Kuss (2014)</h2><span id='topic+KussHeartdat'></span>

<h3>Description</h3>

<p>Dataset for pairwise meta-analysis with many zero entries. Data is from a Cochrane review on
postoperative stroke occurrence when comparing off-pump and on-pump coronary artery
bypass grafting for ischemic heart disease. This data is used as an example in Kuss (2014).
</p>


<h3>Usage</h3>

<pre><code class='language-R'>KussHeartdat
</code></pre>


<h3>Format</h3>

<p>An object of class <code>tbl_df</code> (inherits from <code>tbl</code>, <code>data.frame</code>) with 60 rows and 4 columns.
</p>


<h3>Source</h3>

<p>Kuss O. (2015), Statistical methods for meta-analyses including information
from studies without any events&ndash;add nothing to nothing and succeed nevertheless,
Statist. Med., 34; pages 1097-1116, doi: 10.1002/sim.6383
</p>

<hr>
<h2 id='meta_inla'>Fitting a pairwise meta-analysis model using INLA.</h2><span id='topic+meta_inla'></span>

<h3>Description</h3>

<p><code>meta_inla</code> fits a pairwise meta-analysis model using INLA
</p>


<h3>Usage</h3>

<pre><code class='language-R'>meta_inla(
  datINLA,
  fixed.par = c(0, 1000),
  tau.prior = "uniform",
  tau.par = c(0, 5),
  type = "FE",
  approach = "arm-level",
  mreg = FALSE,
  verbose = FALSE,
  inla.strategy = "simplified.laplace",
  improve.hyperpar.dz = 0.75,
  correct = FALSE,
  correct.factor = 10
)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="meta_inla_+3A_datinla">datINLA</code></td>
<td>
<p>An object of <code>create_INLA_dat_pair</code></p>
</td></tr>
<tr><td><code id="meta_inla_+3A_fixed.par">fixed.par</code></td>
<td>
<p>A numerical vector specifying the parameter of the normal prior
density for mean treatment effect, first value is parameter for mean, second is for variance.</p>
</td></tr>
<tr><td><code id="meta_inla_+3A_tau.prior">tau.prior</code></td>
<td>
<p>A string specifying the prior density for the heterogeneity standard deviation,
options are 'uniform' for uniform prior and 'half-normal' for half-normal prior.</p>
</td></tr>
<tr><td><code id="meta_inla_+3A_tau.par">tau.par</code></td>
<td>
<p>A numerical vector specifying the parameter of the prior
density for heterogenety stdev.
</p>

<ul>
<li> <p><code>var.par = c(u, l)</code>: <code>u</code> is lower bound and <code>l</code> is upper
bound when <code>var.prior = 'uniform'</code>
</p>
</li>
<li> <p><code>var.par = c(m, v)</code>: <code>m</code> is mean and <code>v</code> is variance
when <code>var.prior = 'uniform'</code>
</p>
</li></ul>
</td></tr>
<tr><td><code id="meta_inla_+3A_type">type</code></td>
<td>
<p>A string indicating the type of the model, options are &quot;FE&quot;, &quot;RE&quot;.</p>
</td></tr>
<tr><td><code id="meta_inla_+3A_approach">approach</code></td>
<td>
<p>A string indicating the approach of the model, options are &quot;summary-level&quot;, &quot;arm-level&quot;</p>
</td></tr>
<tr><td><code id="meta_inla_+3A_mreg">mreg</code></td>
<td>
<p>Logical indicating whether covariate(s) should be incorporated to fit a
meta-regression model, default <code>FALSE</code></p>
</td></tr>
<tr><td><code id="meta_inla_+3A_verbose">verbose</code></td>
<td>
<p>Logical indicating whether the program should run in a verbose model, default <code>FALSE</code>.</p>
</td></tr>
<tr><td><code id="meta_inla_+3A_inla.strategy">inla.strategy</code></td>
<td>
<p>A string specfying the strategy to use for the approximations of INLA;
one of 'gaussian', 'simplified.laplace' (default) or 'laplace', see <code>?INLA::control.inla</code>.</p>
</td></tr>
<tr><td><code id="meta_inla_+3A_improve.hyperpar.dz">improve.hyperpar.dz</code></td>
<td>
<p>Step length in the standardized scale used in the construction of the grid, default 0.75,
see <code>INLA::inla.hyperpar</code>.</p>
</td></tr>
<tr><td><code id="meta_inla_+3A_correct">correct</code></td>
<td>
<p>Logical Add correction for the Laplace approximation, default <code>FALSE</code>,
see <code>INLA::inla.hyperpar</code>.</p>
</td></tr>
<tr><td><code id="meta_inla_+3A_correct.factor">correct.factor</code></td>
<td>
<p>Numerical Factor used in adjusting the correction factor if <code>correct=TRUE</code>, default 10,
see <code>INLA::inla.hyperpar</code>.</p>
</td></tr>
</table>


<h3>Details</h3>

<p>The following model types are supported
</p>

<ul>
<li> <p><code>FE</code>, fixed-effect model
</p>
</li>
<li> <p><code>RE</code>, random effects model
</p>
</li></ul>



<h3>Value</h3>

<p><code>meta_inla</code> returns a <code>meta_inla</code> object with components:
</p>


<h3>Examples</h3>

<pre><code class='language-R'>data('TBdat')
## Create the dataset suitable for INLA
TBdatINLA &lt;- create_INLA_dat_pair(TBdat$TRT, TBdat$CON, TBdat$TRTTB, TBdat$CONTB)

## Fitting a random-effects model using arm-level approach
## Not run: 
if(requireNamespace('INLA', quietly = TRUE)){
 require('INLA', quietly = TRUE)
fit.TB.RE.INLA &lt;- meta_inla(TBdatINLA, type = 'RE', approach = 'arm-level',
tau.prior = 'uniform', tau.par = c(0, 5))
}

## End(Not run)

</code></pre>

<hr>
<h2 id='nma_inla'>Fitting a network meta-analysis model using INLA</h2><span id='topic+nma_inla'></span>

<h3>Description</h3>

<p><code>nma_inla</code> fits a network meta-analysis model using INLA.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>nma_inla(
  datINLA,
  likelihood = NULL,
  fixed.par = c(0, 1000),
  tau.prior = "uniform",
  tau.par = c(0, 5),
  kappa.prior = "uniform",
  kappa.par = c(0, 5),
  mreg = FALSE,
  type = "consistency",
  verbose = FALSE,
  inla.strategy = "simplified.laplace",
  improve.hyperpar.dz = 0.75,
  correct = FALSE,
  correct.factor = 10,
  improve.hyperpar = TRUE
)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="nma_inla_+3A_datinla">datINLA</code></td>
<td>
<p>An object of <code>create_INLA_dat</code></p>
</td></tr>
<tr><td><code id="nma_inla_+3A_likelihood">likelihood</code></td>
<td>
<p>The likelihood to be used.</p>
</td></tr>
<tr><td><code id="nma_inla_+3A_fixed.par">fixed.par</code></td>
<td>
<p>A numerical vector specifying the parameter of the normal prior
density for basic parameters, first value is parameter for mean, second is for variance.</p>
</td></tr>
<tr><td><code id="nma_inla_+3A_tau.prior">tau.prior</code></td>
<td>
<p>A string specifying the prior density for the heterogeneity standard deviation,
options are 'uniform' for uniform prior and 'half-normal' for half-normal prior.</p>
</td></tr>
<tr><td><code id="nma_inla_+3A_tau.par">tau.par</code></td>
<td>
<p>A numerical vector specifying the parameter of the prior
density for heterogenety stdev.
</p>

<ul>
<li> <p><code>var.par = c(u, l)</code>: <code>u</code> is lower bound and <code>l</code> is upper
bound when <code>var.prior = 'uniform'</code>.
</p>
</li>
<li> <p><code>var.par = c(m, v)</code>: <code>m</code> is mean and <code>v</code> is variance
when <code>var.prior = 'half-normal'</code>.
</p>
</li></ul>
</td></tr>
<tr><td><code id="nma_inla_+3A_kappa.prior">kappa.prior</code></td>
<td>
<p>A string specifying the prior density for the inconsistency standard deviation,
options are 'uniform' for uniform prior and 'half-normal' for half-normal prior.</p>
</td></tr>
<tr><td><code id="nma_inla_+3A_kappa.par">kappa.par</code></td>
<td>
<p>A numerical vector specifying the parameter of the prior.
density for inconsistency stdev. The definition of the priors is the same as for <code>tau.par</code>.</p>
</td></tr>
<tr><td><code id="nma_inla_+3A_mreg">mreg</code></td>
<td>
<p>Logical indicating whether covariate(s) should be incorporated to fit a
network meta-regression model, default <code>FALSE</code>.</p>
</td></tr>
<tr><td><code id="nma_inla_+3A_type">type</code></td>
<td>
<p>A string indicating the type of the model, options are &quot;FE&quot;, &quot;consistency&quot; and &quot;jackson&quot;.</p>
</td></tr>
<tr><td><code id="nma_inla_+3A_verbose">verbose</code></td>
<td>
<p>Logical indicating whether the program should run in a verbose model, default <code>FALSE</code>.</p>
</td></tr>
<tr><td><code id="nma_inla_+3A_inla.strategy">inla.strategy</code></td>
<td>
<p>A string specfying the strategy to use for the approximations of INLA;
one of 'gaussian', 'simplified.laplace' (default) or 'laplace', see <code>?INLA::control.inla</code>.</p>
</td></tr>
<tr><td><code id="nma_inla_+3A_improve.hyperpar.dz">improve.hyperpar.dz</code></td>
<td>
<p>Step length in the standardized scale used in the construction of the grid, default 0.75,
see <code>INLA::inla.hyperpar</code>. Not used if <code>mod = 'FE'</code>.</p>
</td></tr>
<tr><td><code id="nma_inla_+3A_correct">correct</code></td>
<td>
<p>Logical Add correction for the Laplace approximation, default <code>FALSE</code>,
see <code>INLA::inla.hyperpar</code>. Not used if <code>mod = 'FE'</code>.</p>
</td></tr>
<tr><td><code id="nma_inla_+3A_correct.factor">correct.factor</code></td>
<td>
<p>Numerical Factor used in adjusting the correction factor if <code>correct=TRUE</code>, default 10,
see <code>INLA::inla.hyperpar</code>. Not used if <code>mod = 'FE'</code>.</p>
</td></tr>
<tr><td><code id="nma_inla_+3A_improve.hyperpar">improve.hyperpar</code></td>
<td>
<p>Improve the estimates of the posterior marginals for the hyperparameters
of the model using the grid integration strategy, default <code>TRUE</code>.
see <code>INLA::inla.hyperpar</code>.</p>
</td></tr>
</table>


<h3>Details</h3>

<p>The following likelihood types are supported
</p>

<ul>
<li> <p><code>normal</code>: for continuous (mean difference) data.
</p>
<p>Required coloumns: <code>[mean, std.err]</code>
</p>
<p>Result: relative mean difference
</p>
</li>
<li> <p><code>binomial</code>: for dichotomous data.
</p>
<p>Required coloumns: <code>[responders, sampleSize]</code>
</p>
<p>Result: log odds ratio
</p>
</li>
<li> <p><code>normal</code>: for event-rate (survival) data.
</p>
<p>Required coloumns: <code>[responders, exposure]</code>
</p>
<p>Result: log hazard ratio
</p>
</li></ul>

<p>The following model types are supported
</p>

<ul>
<li> <p><code>FE</code>, ordinary fixed effect model, assuming homogeneity between trials
(Dias et al., 2013)
</p>
</li>
<li> <p><code>consistency</code>, ordinary consistency model, assuming consistency in the
network. (Jackson et al., 2014)
</p>
</li>
<li> <p><code>jackson</code>, the design-by-treatment interaction model with random
inconsistency parameters. (Jackson et al., 2014)
</p>
</li></ul>



<h3>Value</h3>

<p><code>nma_inla</code> returns a <code>nma_inla</code> object.
</p>


<h3>Examples</h3>

<pre><code class='language-R'>SmokdatINLA &lt;- create_INLA_dat(dat = Smokdat, armVars = c('treatment' = 't', 'responders' = 'r'
,'sampleSize' = 'n'), nArmsVar = 'na')
## Not run: 
## Fitting a consistency model
if(requireNamespace('INLA', quietly = TRUE)){
 require('INLA', quietly = TRUE)
fit.Smok.cons.INLA &lt;- nma_inla(SmokdatINLA, likelihood = 'binomial', type = 'consistency',
tau.prior = 'uniform', tau.par = c(0, 5))
}

## End(Not run)

</code></pre>

<hr>
<h2 id='nmaINLA'>nmaINLA: Network meta-analysis using INLA</h2><span id='topic+nmaINLA'></span>

<h3>Description</h3>

<p>An R package for performing network meta-analysis using INLA.
</p>


<h3>Details</h3>

<p>Network meta-analysis is a generalization of pairwise meta-analysis to analyze networks
of trials comparing two or more treatments simultaneously (Dias et al, 2011). Bayesian
hierarchical models are commonly used for network meta-analysis (Dias et al, 2011). The
default choice for performing inference within such models are Markov Chain Monte Carlo
(MCMC), for example using BUGS-variants programs such as JAGS. A deterministic approach
to do fully Bayesian inference for latent Gaussian models (LGMs) are integrated nested
Laplace approximations (INLA) (Rue et al, 2009) which is a fast and accurate alternative
to MCMC. INLA methodology is implemented as an R package INLA (&lt;www.r-inla.org&gt;). Sauter
and Held (2015) has shown that INLA can be used for fitting many NMA models including
fixed effect and consistency models, node-splitting models.
</p>
<p>This package extends the INLA implementation of Sauter and Held (2015) to Jackson
model (Jackson et al, 2014) and network meta-regression and extracts the
features needed for NMA models from INLA R package and presents
in an intuitive way (Guenhan et al, 2018). Currently, contrast-based network
meta-analysis using trial-arm level data for datasets with binary, continuous, and survival outcomes are supported.
Note that the installation of R package
'INLA' is compulsory for successful usage. The 'INLA' package can be obtained from
&lt;http://www.r-inla.org&gt;. We recommend the testing version, which can be downloaded
by running: install.packages(&quot;INLA&quot;,repos=c(getOption(&quot;repos&quot;),
INLA=&quot;https://inla.r-inla-download.org/R/testing&quot;), dep=TRUE).
</p>
<p>Type vignette(&quot;nmaINLA&quot;) to how to use this package.
</p>
<p>The development version of nmaINLA is available on GitHub &lt;https://github.com/gunhanb/nmaINLA&gt;.
</p>


<h3>Author(s)</h3>

<p>Burak Kuersad Guenhan &lt;burakgunhan@gmail.com&gt;
</p>


<h3>Source</h3>

<p>Guenhan, B.K., Friede, T., Held, L. (2018)
A design-by-treatment interaction model for network meta-analysis and meta-regression
with integrated nested Laplace approximations. Res Syn Meth. 2018;1-14. https://doi.org/10.1002/jrsm.1285
</p>
<p>Sauter, R. and Held, L. (2015). Network meta-analysis
with integrated nested Laplace approximations. Biometrical Journal 57 1038&ndash;1050.
</p>
<p>Jackson, D., Barrett, J. K., Rice, S., White, I. R. and Higgins, J. P. (2014).
A design-by-treatment interaction model for network meta-analysis with random
inconsistency effects. Statistics in Medicine 33 3639&ndash;3654.
</p>
<p>Rue, H., Martino, S. and Chopin, N. (2009). Approximate Bayesian inference
for latent Gaussian models by using integrated nested Laplace approximations.
Journal of the Royal Statistical Society: Series B (Statistical Methodology) 71 319&ndash;392.
</p>
<p>Dias, S., Welton, N. J., Sutton, A. J. and Ades, A. (2011). NICE DSU
Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise
and Network Meta-analysis of Randomised Controlled Trials. Last updated September 2016.
</p>
<p>Dias, S., Sutton, A. J., Welton, N. J. and Ades, A. E. (2013). Evidence
synthesis for Decision Making 3: Heterogeneity&ndash;Subgroups, Meta-Regression, Bias,
and Bias-Adjustment. Medical Decision Making 33 618&ndash;640.
</p>

<hr>
<h2 id='Parkinsondat'>Data for the Parkinson NMA-network discussed in Dias et al. (2013)</h2><span id='topic+Parkinsondat'></span>

<h3>Description</h3>

<p>Data are the mean off-time reduction in patients given dopamine
Agonists as adjunct therapy in Parkinson's disease.
The data available are the mean, standard deviation and number of patients
in each trial arm, for 7 studies of five different drugs: placebo,
coded 1, and five active drugs coded 2 to 5.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Parkinsondat
</code></pre>


<h3>Format</h3>

<p>An object of class <code>data.frame</code> with 7 rows and 11 columns.
</p>


<h3>Source</h3>

<p>Dias, S., Welton, N.J., Sutton, A.J. &amp; Ades, A.E. NICE DSU Technical Support Document 2:
A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of
Randomised Controlled Trials. 2011; last updated September 2016; available from
http://www.nicedsu.org.uk
</p>

<hr>
<h2 id='plot_nma'>Plot a network plot</h2><span id='topic+plot_nma'></span>

<h3>Description</h3>

<p>Takes a <code>create_INLA_dat</code> output and plots a network graph.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>plot_nma(
  s.id = "study",
  t.id = "treatment",
  data,
  title = "",
  adjust.figsizex = 1.1,
  adjust.figsizey = 1.1
)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="plot_nma_+3A_s.id">s.id</code></td>
<td>
<p>Variable holding the study IDs for each study. The default is &quot;study&quot;.</p>
</td></tr>
<tr><td><code id="plot_nma_+3A_t.id">t.id</code></td>
<td>
<p>Variable holding the treatments for each study. The default is &quot;treatment&quot;.</p>
</td></tr>
<tr><td><code id="plot_nma_+3A_data">data</code></td>
<td>
<p>A <code>create_INLA_dat</code> object.</p>
</td></tr>
<tr><td><code id="plot_nma_+3A_title">title</code></td>
<td>
<p>A character string indicating plot title.</p>
</td></tr>
<tr><td><code id="plot_nma_+3A_adjust.figsizex">adjust.figsizex</code></td>
<td>
<p>a positive number used to adjust the plot width. The default is 1.1.</p>
</td></tr>
<tr><td><code id="plot_nma_+3A_adjust.figsizey">adjust.figsizey</code></td>
<td>
<p>a positive number used to adjust the plot height. The default is 1.1.</p>
</td></tr>
</table>


<h3>Author(s)</h3>

<p>Lifeng Lin, Jing Zhang, and Haitao Chu
</p>


<h3>Source</h3>

<p>This function is taken from <code>nma.networkplot</code> function from <code>pcnetmeta</code> R package.
</p>


<h3>See Also</h3>

<p><code>pcnetmeta::nma.networkplot</code>
</p>

<hr>
<h2 id='print.nma_inla'>Print nmainla object</h2><span id='topic+print.nma_inla'></span>

<h3>Description</h3>

<p>Takes an <code>nma_inla</code> object which is obtained by function <code>nma_inla</code> and print
the model and data information such as model type used in the model.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>## S3 method for class 'nma_inla'
print(x, digits = 3, ...)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="print.nma_inla_+3A_x">x</code></td>
<td>
<p>An <code>nma_inla</code> object.</p>
</td></tr>
<tr><td><code id="print.nma_inla_+3A_digits">digits</code></td>
<td>
<p>An integer indicating the number of decimal places.</p>
</td></tr>
<tr><td><code id="print.nma_inla_+3A_...">...</code></td>
<td>
<p>Further arguments passed to or from other methods.</p>
</td></tr>
</table>


<h3>Details</h3>

<p>The resulting data.frame can be used as data argument in <code>nma_inla</code>.
</p>


<h3>Value</h3>

<p>The return value is invisible <code>NULL</code>
</p>

<hr>
<h2 id='Smokdat'>Data for the smoking cessation NMA-network discussed in Dias et al. (2010)</h2><span id='topic+Smokdat'></span>

<h3>Description</h3>

<p>The smoking cessation dataset describes a network comparing 4 treatments with 24 trials.
There are 22 pairwise comparisons and 2 thee-arm trials.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Smokdat
</code></pre>


<h3>Format</h3>

<p>A data frame with 24 observations on the following 10 variables.
</p>

<dl>
<dt><code>r1</code></dt><dd><p>Number of events (responses) in the baseline treatment (treatment
1).</p>
</dd>
<dt><code>r2</code></dt><dd><p>Number of events (responses) in the second study arm treatment
(treatment 2).</p>
</dd>
<dt><code>r3</code></dt><dd><p>Number of events (responses) in the third study arm treatment
(treatment 3).</p>
</dd>
<dt><code>n1</code></dt><dd><p>Total number of study participants in the baseline
treatment (treatment 1).</p>
</dd>
<dt><code>n2</code></dt><dd><p>Total number of study participants in the second study arm
treatment (treatment 2).</p>
</dd>
<dt><code>n3</code></dt><dd><p>Total number of study participants in the second study arm
treatment (treatment 3).</p>
</dd>
<dt><code>t1</code></dt><dd><p>Indicator variable identifying treatment 1.</p>
</dd>
<dt><code>t2</code></dt><dd><p>Indicator variable identifying treatment 2.</p>
</dd>
<dt><code>t3</code></dt><dd><p>Indicator variable identifying treatment 3.</p>
</dd>
<dt><code>na</code></dt><dd><p>Indicator with number of arms in trial.</p>
</dd>
<dt><code>des</code></dt><dd><p>Design, the set of treatments included in each study</p>
</dd>
</dl>



<h3>Source</h3>

<p>Dias, S., Welton, N. J., Caldwell, D. M. and Ades, A. E. (2010)
Checking consistency in mixed treatment comparison meta-analysis,
Statistics in Medicine, 29:932&ndash;944.
</p>

<hr>
<h2 id='Strokedat'>Data for the Stroke NMA regression discussed in Batson et al. (2016)</h2><span id='topic+Strokedat'></span>

<h3>Description</h3>

<p>Dataset for network meta-regression of stroke prevention in Atrial Fibrillation.
A total of 19 studies, and primary endpoint is reported ischaemic stroke. It includes 15 comparators
which include fixed low dose warfarin with or without aspirin, aspirin monotherapy, aspirin plus
clopidogrel, indobufen, idraparinux, triflusal and ximelagatran. Study level covariates are the proportion of
patients with a previous stroke/TIA, proportion of males, mean age, and the duration of study.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Strokedat
</code></pre>


<h3>Format</h3>

<p>An object of class <code>data.frame</code> with 19 rows and 18 columns.
</p>


<h3>Source</h3>

<p>Batson S, Sutton A, Abrams K (2016) Exploratory Network Meta Regression Analysis of
Stroke Prevention in Atrial Fibrillation Fails to Identify
Any Interactions with Treatment Effect. PLoS ONE 11
</p>

<hr>
<h2 id='TBdat'>Trials investigating effectiveness of the BCG vaccine against TB</h2><span id='topic+TBdat'></span>

<h3>Description</h3>

<p>A dataset containing the results from 13 trials examining the efficacy
of Bacillus Calmette-Guerin (BCG) vaccine against tuberculosis (TB).
</p>


<h3>Usage</h3>

<pre><code class='language-R'>TBdat
</code></pre>


<h3>Format</h3>

<p>A data frame with following coloumns
</p>

<dl>
<dt>Trial</dt><dd><p>Trial number</p>
</dd>
<dt>TRTTB</dt><dd><p>number of TB events in treatment arm</p>
</dd>
<dt>TRT</dt><dd><p>number of subjects in treatment arm</p>
</dd>
<dt>CONTB</dt><dd><p>number of TB events in control arm</p>
</dd>
<dt>CON</dt><dd><p>number of subjects in control arm</p>
</dd>
<dt>Latitude</dt><dd><p>absolute latitude of the study location</p>
</dd>
</dl>



<h3>Source</h3>

<p>Berkey, C.S., Hoaglin, D.C., Mosteller, F. and Colditz,
G.A., 1995. A random-effects regression model for meta-analysis. Statistics in medicine, 14(4), pp.395-411
</p>

<hr>
<h2 id='Thrombdat'>Data for the thrombolytic NMA-network discussed in Dias et al. (2010)</h2><span id='topic+Thrombdat'></span>

<h3>Description</h3>

<p>The thrombolytic dataset describes a network comparing 9 treatments with 50 trials.
There are 22 pairwise comparisons and 2 thee-arm trials.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Thrombdat
</code></pre>


<h3>Format</h3>

<p>A data frame with 50 observations on the following 11 variables.
</p>

<dl>
<dt><code>r1</code></dt><dd><p>Number of events (responses) in the baseline treatment (treatment
1).</p>
</dd>
<dt><code>r2</code></dt><dd><p>Number of events (responses) in the second study arm treatment
(treatment 2).</p>
</dd>
<dt><code>r3</code></dt><dd><p>Number of events (responses) in the third study arm treatment
(treatment 3).</p>
</dd>
<dt><code>n1</code></dt><dd><p>Total number of study participants in the baseline
treatment (treatment 1).</p>
</dd>
<dt><code>n2</code></dt><dd><p>Total number of study participants in the second study arm
treatment (treatment 2).</p>
</dd>
<dt><code>n3</code></dt><dd><p>Total number of study participants in the second study arm
treatment (treatment 3).</p>
</dd>
<dt><code>t1</code></dt><dd><p>Indicator variable identifying treatment 1.</p>
</dd>
<dt><code>t2</code></dt><dd><p>Indicator variable identifying treatment 2.</p>
</dd>
<dt><code>t3</code></dt><dd><p>Indicator variable identifying treatment 3.</p>
</dd>
<dt><code>na</code></dt><dd><p>Indicator with number of arms in trial.</p>
</dd></dl>



<h3>Source</h3>

<p>Dias, S., Welton, N. J., Caldwell, D. M. and Ades, A. E. (2010)
Checking consistency in mixed treatment comparison meta-analysis,
Statistics in Medicine, 29:932&ndash;944.
</p>

<hr>
<h2 id='Woodsdat'>Data for the Woods example in Woods et al. (2010)</h2><span id='topic+Woodsdat'></span>

<h3>Description</h3>

<p>Count mortality statistics in randomised controlled 
trials of treatments for chronic obstructive pulmonary disease (Woods et al. (2010), Table 1)
</p>


<h3>Usage</h3>

<pre><code class='language-R'>Woodsdat
</code></pre>


<h3>Format</h3>

<p>An object of class <code>data.frame</code> with 3 rows and 14 columns.
</p>


<h3>Source</h3>

<p>Woods BS, Hawkins N, Scott DA (2010). Network meta-analysis on the log-hazard scale, 
combining count and hazard ratio statistics accounting for multi-arm trials: A tutorial. 
BMC Medical Research Methodology 10, 54.
</p>

</main>

</div>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/prism.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/components/prism-r.min.js"></script>
</body></html>
